Research library · Genomics
A copy-number change is about how much DNA is present
Draft • Research checked 4 October 2026 • AI-assisted DomDNA editorial content. No independent clinical review or publication is claimed. General education, not individual medical advice.
Most introductory DNA examples show one letter changing into another. A copy-number variant asks a different question: has a segment been lost or repeated? A report describing a deletion or duplication is therefore not just a long list of single-letter substitutions.
Understanding the type of change helps you read the report without treating its size as a severity score. The important information includes what segment is involved, what the test can establish and how the finding was interpreted.
Read the kind of change first
The NHGRI copy-number glossary defines variation in the number of copies of a DNA segment. A segment may contain genes, part of a gene or other sequence.
A hypothetical teaching example uses a short stretch normally represented twice in an autosomal genome. If a test identifies one copy instead, the finding concerns a deletion; if it identifies three, it concerns a duplication. The example explains counting, not the effect of any real genomic region.
It would be wrong to conclude that three copies mean “fifty per cent better function”, or that one copy means “half the function” in every case. Gene regulation and clinical effects do not follow that arithmetic automatically.
A copy-number change also differs from a rearrangement that moves or reverses material without changing the total amount. The type matters to what an assay can detect.
Amount and location are different questions
The NHS microarray explanation describes testing for copy-number changes and notes limits on structural or positional information. Identifying extra material does not always show where the extra copy sits or how it is arranged.
Imagine a hypothetical report that identifies a duplicated segment. A diagram showing the new copy immediately beside the original might be an attractive illustration, but it could add information the test did not establish. A faithful diagram would label the arrangement as unknown unless the report resolves it.
This is why a report can contain a confident copy-number finding and still leave a structural question open. The uncertainty concerns a different aspect of the genome, not necessarily disagreement about whether extra material exists.
Keep those questions separate when comparing tests. A method useful for a copy-number question may not provide every sequence or positional detail.
Bigger is not a universal ranking
A large deletion can involve many genes; a smaller change can affect an important part of a gene. Size alone cannot rank the clinical effect of all findings.
The NHS duplication resource explains that clinical relevance depends on the region and genes involved. That statement does not allow a reader to diagnose a syndrome from the length of a segment in a raw-data tool.
If a report uses a classification term, retain it with the finding. Do not replace an uncertain classification with “major mutation” because the segment spans many letters. Equally, do not dismiss a finding as harmless merely because it is described as small.
Family information can sometimes contribute to interpretation, but resemblance to a relative is not a self-contained test of significance. Decisions about testing relatives should remain within an appropriate clinical discussion.
A hypothetical summary repair
Suppose a personal note says, “A large DNA error was found.” The wording combines an observation with an interpretation and provides little usable detail.
A more useful summary would say that a deletion or duplication was reported, identify the report date and the relevant region as written, and preserve the laboratory's classification. If the arrangement was not established, the note should say so.
That summary does not need to reproduce a chromosome map. Its purpose is to stop a shorthand phrase from losing the kind of change and the uncertainty attached to it.
Avoid forwarding screenshots of a child's or relative's result without their involvement and an appropriate reason. Genomic findings can concern more than one person, while still belonging to an individual medical record.
What you can do with this
Before reading a copy-number result as a letter-change result, check its variant type. Then keep the region, copy-number statement, classification and method together. Ask which further question, if any, remains unresolved.
The useful next step is report organisation, not self-classification. A properly labelled finding is easier to explain and less likely to acquire unsupported claims as it moves between people.
For general lifestyle learning, DomDNA’s educational quiz does not detect deletions, duplications or other DNA changes.
Original source and access ledger
- NHGRI copy-number variation glossary
sourceDate: 2026-10-02
type: Official glossary
population: DNA segments across genomes
endpoint: Copy-number definition
supportedClaimAndLimit: Copy number concerns deletion or duplication of segments; no linear gene-function or severity arithmetic.
fundingAndConflicts: Official resource or project documentation; not a personal-benefit trial or endorsement. Institutional authorship does not establish clinical review of this draft.
accessEvidence: Official source page, documentation or primary abstract text accessed via web search/open on 2026-10-04. Indexed text was used where direct opening was incomplete; no complete study-methods or supplement appraisal claimed.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction, policy-version or guideline surveillance claimed.
sourceWordLimit: 200
quoteWords: 0
sourceUseBudget: 200-word aggregate source-derived limit across article and adaptations; no verbatim quotations. Short central claims retained; hypothetical examples and administrative suggestions are original editorial material, not study findings.
- NHS microarray explanation
sourceDate: 2024-07-18; displayed next-review date 2026-07-18 has passed
type: Official clinical education
population: Clinical copy-number testing
endpoint: Amount and structural-information limits
supportedClaimAndLimit: Microarray can assess copy-number changes without resolving arrangement; no current referral-policy claim.
fundingAndConflicts: Official resource or project documentation; not a personal-benefit trial or endorsement. Institutional authorship does not establish clinical review of this draft.
accessEvidence: Official source page, documentation or primary abstract text accessed via web search/open on 2026-10-04. Indexed text was used where direct opening was incomplete; no complete study-methods or supplement appraisal claimed.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction, policy-version or guideline surveillance claimed.
sourceWordLimit: 200
quoteWords: 0
sourceUseBudget: 200-word aggregate source-derived limit across article and adaptations; no verbatim quotations. Short central claims retained; hypothetical examples and administrative suggestions are original editorial material, not study findings.
- NHS duplications and microduplications
sourceDate: 2025-04-14
type: Official clinical education
population: Duplicated DNA regions
endpoint: Region-dependent interpretation
supportedClaimAndLimit: Relevance depends on the region and genes, not a universal size ranking; no self-classification of a personal finding.
fundingAndConflicts: Official resource or project documentation; not a personal-benefit trial or endorsement. Institutional authorship does not establish clinical review of this draft.
accessEvidence: Official source page, documentation or primary abstract text accessed via web search/open on 2026-10-04. Indexed text was used where direct opening was incomplete; no complete study-methods or supplement appraisal claimed.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive correction, retraction, policy-version or guideline surveillance claimed.
sourceWordLimit: 200
quoteWords: 0
sourceUseBudget: 200-word aggregate source-derived limit across article and adaptations; no verbatim quotations. Short central claims retained; hypothetical examples and administrative suggestions are original editorial material, not study findings.
Download exact original article Markdown · Download exact source and unsent social pack
Finished companion media
Silent films, slides and source captions on the separate dashboard. Original preview and historical product limits remain in their captions. No social campaign has been sent.